Back to mobile site

AtriCure (ATRC) Tops Q3 EPS by 2c

November 1, 2017 4:08 PM EDT

AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $42.2 million versus the consensus estimate of $43.44 million.

Guidance:

Sees FY 2017 revenues up 11-13%

For earnings history and earnings-related data on AtriCure (ATRC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings